Research


Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio

with David E. Fagnan, N. Nora Yang, John C. McKew, Science Translational Medicine 7(2015), 276ps3.

View abstract

Can Hedge Funds Time Market Liquidity?

with Charles Cao, Yong Chen, Bing Liang, Journal of Financial Economics

View abstract

Learning Connections in Financial Time Series

with Gartheeban Ganeshapillai, John Guttag, Proceedings of the 30th International Conference on Machine Learning (ICML-13) 30, 109-117

View abstract

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

with Sourya V. Naraharisetti, Journal of Investment Management

View abstract

Financing Drug Discovery for Orphan Diseases

with David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein, Drug Discovery Today 19 (2014), 533-538

View abstract

Financial Orphan Therapies Looking For Adoption

with Vikas Sukhatme, Kathy Fang, Vidula Sukhatme, Health Affairs Blog

View abstract

Parallel Discovery of Alzheimer’s Therapeutics

with Carole Ho, Jayna Cummings, Kenneth S. Kosik, Science Translational Medicine 241(6), 1-8

View abstract

Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

with Tito Fojo, Sham Mailankody, JAMA Otolaryngology-Head & Neck Surgery (2014)

View abstract

The Origin of Bounded Rationality and Intelligence

Proceedings of the American Philosophical Society 157 (2013), 269-280.

View abstract

Group Selection as Behavioral Adaptation to Systematic Risk

with Ruixun Zhang, Thomas J. Brennan, PLOS One 9 (2014)

View abstract


Follow me on © 2018 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design